IV7 is a green disinfectant and not a sterilant. Who do you think is going to pay $144 million for a overpriced disinfectant? Maybe those are estimates on how many suckers they can pull in through the "Amwayish" ponzi scheme. If they can introduce a sterilant which outperforms others, it may change the ball game.
How about those new 100 million AS your ceo will add shortly, you think they're just going sit in the treasury?
News 
Market Data 
Discover 
AI
